Schubiger PA - Search Results

1

[76Br]Bromodeoxyuridine, a potential tracer for the measurement of cell proliferation by positron emission tomography, in vitro and in vivo studies in mice.

Ryser JE, Bläuenstein P, Rémy N, Weinreich R, Hasler PH, Novak-Hofer I, Schubiger PA. Ryser JE, et al. Among authors: schubiger pa. Nucl Med Biol. 1999 Aug;26(6):673-9. doi: 10.1016/s0969-8051(99)00042-6. Nucl Med Biol. 1999. PMID: 10587106

2

In vitro and in vivo testing of the dopamine D1 ligand [123I]SCH 23982 with respect to its potential application in SPET investigations.

Beer HF, Lin S, Bläuenstein P, Hasler P, Schubiger PA, Maier A, Lichtensteiger W, Oettli R, Bekier A, Weder B. Beer HF, et al. Among authors: schubiger pa. Nucl Med Biol. 1993 Jul;20(5):607-16. doi: 10.1016/0969-8051(93)90029-t. Nucl Med Biol. 1993. PMID: 8358346

3

123I-labeling and evaluation of Ro 43-0463, a SPET tracer for MAO-B imaging.

Beer HF, Rossetti I, Frey LD, Hasler PH, Schubiger PA. Beer HF, et al. Among authors: schubiger pa. Nucl Med Biol. 1995 Oct;22(7):929-936. doi: 10.1016/0969-8051(95)00041-u. Nucl Med Biol. 1995. PMID: 8547891

4

In vivo properties of N-(2-aminoethyl)-5-halogeno-2-pyridinecarboxamide 18F- and 123I-labelled reversible inhibitors of monoamine oxidase B.

Bläuenstein P, Rémy N, Buck A, Ametamey S, Häberli M, Schubiger PA. Bläuenstein P, et al. Among authors: schubiger pa. Nucl Med Biol. 1998 Jan;25(1):47-52. doi: 10.1016/s0969-8051(97)00143-1. Nucl Med Biol. 1998. PMID: 9466361

5

Non-invasive assessment of tumour cell proliferation with positron emission tomography and [76Br]bromodeoxyuridine.

Böni R, Bläuenstein P, Dummer R, von Schulthess GK, Schubiger PA, Steinert HC. Böni R, et al. Among authors: schubiger pa. Melanoma Res. 1999 Dec;9(6):569-73. doi: 10.1097/00008390-199912000-00005. Melanoma Res. 1999. PMID: 10661767

6

Targeting of renal carcinoma with 67/64Cu-labeled anti-L1-CAM antibody chCE7: selection of copper ligands and PET imaging.

Zimmermann K, Grünberg J, Honer M, Ametamey S, Schubiger PA, Novak-Hofer I. Zimmermann K, et al. Among authors: schubiger pa. Nucl Med Biol. 2003 May;30(4):417-27. doi: 10.1016/s0969-8051(03)00019-2. Nucl Med Biol. 2003. PMID: 12767399

7

Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors.

García-Garayoa E, Maes V, Bläuenstein P, Blanc A, Hohn A, Tourwé D, Schubiger PA. García-Garayoa E, et al. Among authors: schubiger pa. Nucl Med Biol. 2006 May;33(4):495-503. doi: 10.1016/j.nucmedbio.2006.01.007. Epub 2006 May 2. Nucl Med Biol. 2006. PMID: 16720241

8

Evaluation of 177Lu-DOTA-labeled aglycosylated monoclonal anti-L1-CAM antibody chCE7: influence of the number of chelators on the in vitro and in vivo properties.

Knogler K, Grünberg J, Novak-Hofer I, Zimmermann K, Schubiger PA. Knogler K, et al. Among authors: schubiger pa. Nucl Med Biol. 2006 Oct;33(7):883-9. doi: 10.1016/j.nucmedbio.2006.08.001. Nucl Med Biol. 2006. PMID: 17045168

9

Copper-67 as a therapeutic nuclide for radioimmunotherapy.

Novak-Hofer I, Schubiger PA. Novak-Hofer I, et al. Among authors: schubiger pa. Eur J Nucl Med Mol Imaging. 2002 Jun;29(6):821-30. doi: 10.1007/s00259-001-0724-y. Epub 2002 Feb 2. Eur J Nucl Med Mol Imaging. 2002. PMID: 12029558 Review.

10

Radioimmunolocalization of neuroblastoma xenografts with chimeric antibody chCE7.

Novak-Hofer I, Amstutz HP, Haldemann A, Blaser K, Morgenthaler JJ, Bläuenstein P, Schubiger PA. Novak-Hofer I, et al. Among authors: schubiger pa. J Nucl Med. 1992 Feb;33(2):231-6. J Nucl Med. 1992. PMID: 1732444 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters